Skip to main content
Log in

The pharmacokinetics of fluconazole during haemodialysis in uraemic patients

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

We have studied the pharmacokinetics of fluconazole in five patients on long-term haemodialysis. The single-pass extraction rate of the dialyzer was 59 (3.5) % (n=4), and the serum concentration was reduced by haemodialysis for 3 or 4 h by 26 (3.2) % (n=5) and 39 (2.2) % (n=9) respectively. The estimated amount extracted by a dialysis of 4 h was 33 (3.2) % (n=4) of the dose. During repeated administration the serum fluconazole concentration increased, reaching a plateau at about 4 times the peak concentration after the first dose. After discontinuing administration the serum fluconazole concentration fell by 25% in every 3 h dialysis session. We conclude that fluconazole should be given in the usual dose of 100 or 200 mg at the end of every haemodialysis session.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jevons S, Lees L, Tarbit M (1985) Early clinical experience with UK-49,858 in human volunteers and patients. Proceedings of the 14th International Congress Chemotherapy 1938–1939 University of Tokyo Press

  2. Dupont B, Drouhet E (1987) Cryptococcal meningitis and fluconazole. Ann Intern Med 106: 778–781

    Google Scholar 

  3. Humphrey MJ, Jevons S, Tarbit MH (1985) Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug in animal and humans. Antimicr Agents Chemother 28: 648–653

    Google Scholar 

  4. Obayashi T, Tamura H, Tanaka S (1986) Endotoxin-inactivating activity in normal and pathological human blood samples. Infect Immun 53: 294–297

    Google Scholar 

  5. Wood PR, Tarbit MH (1986) Gas chromatographic method for the determination of fluconazole, a novel antifungal agent, in human plasma and urine. J Chromatogr 383: 179–186

    Google Scholar 

  6. Ikemoto H, Watanabe K, Mori T (1989) Clinical study of fluconazole on deep-seated fungal infections. Jap J Antibiotics 42: 63–116

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oono, S., Tabei, K., Tetsuka, T. et al. The pharmacokinetics of fluconazole during haemodialysis in uraemic patients. Eur J Clin Pharmacol 42, 667–669 (1992). https://doi.org/10.1007/BF00265934

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00265934

Key words

Navigation